Pharmafile Logo
Pharmafocus logo
Advanced Search

IQWIG

Showing 7 posts of 7 posts found.

iqwigsmall

Eisai “cannot understand” German agency’s recommendation to reject Halaven

September 6, 2016
Manufacturing and Production, Research and Development Eisai, Germany, Halaven, IQWIG, german

Eisai has issued a statement to declare their “bewilderment” following a decision from the German Institute for Quality and Efficiency …

News
Germany image

Germany focus: strength with control

February 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AMNOG, EFPIA, Germany, IQWIG, NHS, NICE

Germany is the biggest pharmaceutical market in Europe and one of the biggest in the world, but new systems and …

Feature

Germany to cut drug prices by 2 billion euro

November 12, 2010
Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines

The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …

News

Watchdog resignation forced ‘to appease pharma’

September 6, 2010
Sales and Marketing Germany, IQWIG

The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …

News

German price cuts denounced by industry

March 30, 2010
Sales and Marketing Germany, IQWIG

Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …

News

EU should require all trials to be registered, says IQWiG

December 1, 2009
Sales and Marketing Germany, IQWIG, health economics, hta

 Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …

News

The Pharmafocus Interview: Elmar Schnee

January 6, 2009
Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness

Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025